PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2014. The put-call ratio across all filers is 2.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,432,000 | -37.6% | 675,286 | -1.4% | 0.00% | -33.3% |
| Q3 2016 | $2,295,000 | +6.2% | 685,096 | -0.4% | 0.00% | 0.0% |
| Q2 2016 | $2,160,000 | +5.4% | 687,978 | +11.8% | 0.00% | 0.0% |
| Q1 2016 | $2,050,000 | -5.8% | 615,620 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $2,177,000 | -29.4% | 614,958 | +0.3% | 0.00% | -25.0% |
| Q3 2015 | $3,085,000 | -21.3% | 613,242 | +0.6% | 0.00% | -20.0% |
| Q2 2015 | $3,919,000 | +24.6% | 609,426 | +36.3% | 0.01% | +25.0% |
| Q1 2015 | $3,146,000 | -7.3% | 447,124 | +1.6% | 0.00% | 0.0% |
| Q4 2014 | $3,394,000 | +2.7% | 440,177 | -0.5% | 0.00% | -20.0% |
| Q3 2014 | $3,305,000 | -22.3% | 442,480 | +0.7% | 0.01% | -16.7% |
| Q2 2014 | $4,251,000 | +15.2% | 439,201 | -1.1% | 0.01% | +20.0% |
| Q1 2014 | $3,690,000 | +12.7% | 443,990 | +14.4% | 0.01% | 0.0% |
| Q4 2013 | $3,275,000 | +3.1% | 387,990 | -2.7% | 0.01% | 0.0% |
| Q3 2013 | $3,177,000 | +10.6% | 398,593 | +7.1% | 0.01% | 0.0% |
| Q2 2013 | $2,873,000 | – | 372,104 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |